Application of Autogenous Vaccine for the Treatment of Bovine Cutaneous Papillomatosis Type 2 in Malaysia

Abstract

This is the first case report highlighting the application of an in-house autogenous vaccine for the treatment of bovine cutaneous papillomatosis Type 2 in a Jersey crossbred cow in Malaysia. A sample of papilloma growth was excised, homogenised, treated using 0.5% (v/v) formalin and performed microbiological examinations for sterility check. The solution was then administered subcutaneously to the cattle at seven days interval for four weeks. The papilloma growth on the affected cattle regressed rapidly following treatment, and there were no undesirable side effects and recurrences observed. The use of autogenous vaccine as an alternative treatment for bovine papillomatosis is preferred over surgical excision as it is proven effective, safe, and low chances of recurrence.

Surgical interventions of udder and teat affections in dairy cows

“…Udder myiasis was treated successfully with complete recovery, which was similar with the treatment procedures of Rahman et al (2009). The uses of autogenous vaccine for udder and teat papilloma (wart) were effective and corresponding to the researches of Khalid et al (2021), Nethra and Babu (2018) and Kale et al (2019). The management procedures of teat canal polyps, superficial teat cracks and teat sores were feasible to bring positive outcomes in terms of morphology and function of mammary tissue, and were collateral as described by Rathod et al (2009), Nouh et al (2014), Khan et al (2020) and Sharma et al (2020).…”